Nanoparticle Clearance and New Horizons in Engineered Drug Delivery

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Nanomedicine leverages engineered nanoparticles to enhance drug stability, targeting, controlled release, and biocompatibility.
• Clinical success of nanoparticles depends on delivery efficiency, metabolism, retention, and clearance.
• Understanding nanoparticle clearance pathways is crucial for effective therapeutic applications.

Purpose of the Study:

• To review biological pathways governing nanoparticle clearance.
• To discuss how engineering parameters influence nanoparticle bioaccumulation, metabolism, excretion, and therapeutic performance.
• To explore how nanoparticle clearance can be rationally controlled as a design parameter.

Main Methods:

• Narrative review of recent and foundational literature on medically relevant nanoparticles.
• Literature search from January 1971 to January 2026 in PubMed for translational, biochemical, chemical, and clinical studies.
• Analysis of nanoparticle composition, size, surface chemistry, and administration route effects on clearance.

Main Results:

• Nanoparticle clearance is governed by complex molecular and organ-level processes.
• Surface modifications (e.g., PEGylation, zwitterionic coatings) can alter circulation time, immune recognition, and organ handling.
• Clearance kinetics can be tuned; rapid clearance is suitable for some drugs, while prolonged retention may benefit others (e.g., boron neutron capture therapy).

Conclusions:

• Nanoparticle clearance is a tunable design parameter, not a universal limitation.
• Rational control of clearance kinetics can enhance safety and therapeutic effectiveness.
• Optimizing nanoparticle clearance is key for next-generation engineered drug delivery systems.